(Q44194149)

30 November 2017

title

State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia (English)

1 reference

30 November 2017

0 references

Dror N

1

1 reference

30 November 2017

Klein E

2

1 reference

30 November 2017

Karry R

3

1 reference

30 November 2017

Sheinkman A

4

1 reference

30 November 2017

Kirsh Z

5

1 reference

30 November 2017

Mazor M

6

1 reference

30 November 2017

Tzukerman M

7

1 reference

30 November 2017

Ben-Shachar D

8

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

7

1 reference

30 November 2017

issue

9

1 reference

30 November 2017

page(s)

995-1001

1 reference

The positive-negative distinction in schizophrenia. Review of natural history validators

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

A selective review of recent North American long-term followup studies of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Neurotransmitter interactions in schizophrenia--therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Second messenger imbalance hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Schizophrenia as a developmental disorder of the cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Autoimmunity in schizophrenia: a review of recent findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Frontal lobes, basal ganglia, temporal lobes--three sites for schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Mitochondrial involvement in schizophrenia and other functional psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Superoxide, neuroleptics and the ubiquinone and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

The mitochondrial electron transport and oxidative phosphorylation system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Neuroleptic medications inhibit complex I of the electron transport chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Platelets as a model for neurones?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Platelets and psychiatry: lessons learned from old and new studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Platelets as models: use and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Mitochondrial complex I deficiency in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Dopamine Neurotoxicity: Inhibition of Mitochondrial Respiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Isolation of subcellular organelles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

Increased mitochondrial complex I activity in platelets of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

inferred from DOI database lookup

7 January 2021

based on heuristic

Cytochrome oxidase deficiency in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

inferred from DOI database lookup

7 January 2021

based on heuristic

Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001116

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.MP.4001116

1 reference

Dimensions Publication ID

30 November 2017

1024370149

0 references

1 reference